Amedisys (AMED) PT Raised to $60 at Baird Following 3Q

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Amedisys (AMED) PT Raised to $60 at Baird Following 3Q

Benchmark Downgrades Amedisys (AMED) to Hold

November 9, 2017 9:28 AM EST

Benchmark downgraded Amedisys (NASDAQ: AMED) from Buy to Hold.

For an analyst ratings summary and ratings history on Amedisys click here. For more ratings news on Amedisys click here.

Shares of Amedisys closed at $58.49 yesterday.

... More

Amedisys (AMED) PT Raised to $64 at Jefferies

November 8, 2017 8:35 AM EST

Jefferies raised its price target on Amedisys (NASDAQ: AMED) to $64.00 (from $60.00) while maintaining a Buy rating following Q3.

Analyst Brian Tanquilut said the 5% SS increase in Medicare episodes highlights early traction the company is seeing with its revamped sales force and growth initiatives.

... More